Skip to main content
. 2024 Mar 8;47(9):2313–2323. doi: 10.1007/s40618-024-02324-3

Table 2.

Cox proportional HRs and 95% CI for incident T2D according to quartiles of baseline predicted serum vitamin D

Q1 Q2 Q3 Q4 p trend Each 10 ng/mLd
Predicted vit Da 17.62 (16.51;18.23) 19.27 (18.96;19.56) 20.44 (20.12;20.80) 22.39 (21.69;23.48)
Cases of incident T2D 118 43 32 16
Person-years 58,110 60,500 60,422 59,046
Incident rate 10–3 2.0 0.7 0.5 0.3
Age- and sex-adjusted model 1.00 (reference) 0.40 (0.28–0-57) 0.35 (0.24–0.52) 0.20 (0.12–0.34)  < 0.001 0.07 (0.04–0.13)
Multiple-adjusted model1b 1.00 (reference) 0.46 (0.32–0.67) 0.48 (0.31–0.74) 0.32 (0.17–0.57)  < 0.001 0.11 (0.06–0.23)
Multiple-adjusted model2c 1.00 (reference) 0.65 (0.44–0.95) 0.71 (0.45–1.10) 0.48 (0.26–0.88) 0.032 0.31 (0.14–0.68)

aPredicted vitamin D status (ng/mL) expressed by p50 (p25;p75)

bModel adjusted for sex, age, marital status, smoking status (current, former or never smoker), smoking pack-years, weight change, years of university, TV hours/day, family history of T2D, physical activity (MET-h/week), Trichopoulou’s 9-point score/Mediterranean dietary pattern, energy intake (kcal/day), sugar-sweetened beverage consumption (servings/day), snacking, following a special diet, prevalent hypertension, prevalent cancer, prevalent hypercholesterolemia, prevalent hypertriglyceridemia

cModel 1 additionally adjusted for obesity (>=30 kg/m2 yes, no)

dHR and 95% CI for incident T2D for each 10 ng/mL increase of predicted vitamin D